Tirzepatide Weight Loss Injection Tirzepatide has become one of the biggest names in weight loss medication for a reason
Cooper DY, Schleyer H, Rosenthal O, Levin W, Lu AY, Kuntzman R, Conney AH: Inhibition by CO of hepatic benzo[a]pyrene hydroxylation and its reversal by monochromatic light
A fresh pharmacological approach resets some of the adaptive mechanisms that cause plateaus
Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
We will see you next time on the podcast